Cargando…

Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration

Schistosomiasis is one of the most important neglected tropical diseases (NTDs) affecting millions of people in 79 different countries. The World Health Organization (WHO) has specified two control goals to be achieved by 2020 and 2025 - morbidity control and elimination as a public health problem (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kura, Klodeta, Collyer, Benjamin S., Toor, Jaspreet, Truscott, James E., Hollingsworth, T. Deirdre, Keeling, Matt J., Anderson, Roy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273196/ https://www.ncbi.nlm.nih.gov/pubmed/32418795 http://dx.doi.org/10.1016/j.vaccine.2020.04.078

Ejemplares similares

Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019)

Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
por: Ayabina, Diepreye, et al.
Publicado: (2021)

The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
por: Kura, Klodeta, et al.
Publicado: (2020)

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
por: Kura, Klodeta, et al.
Publicado: (2022)

Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
por: Kura, Klodeta, et al.
Publicado: (2021)

What is the impact of acquired immunity on the transmission of schistosomiasis and the efficacy of current and planned mass drug administration programmes?
por: Kura, Klodeta, et al.
Publicado: (2021)

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020)

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
por: Toor, Jaspreet, et al.
Publicado: (2019)

Human population movement can impede the elimination of soil-transmitted helminth transmission in regions with heterogeneity in mass drug administration coverage and transmission potential between villages: a metapopulation analysis
por: Vegvari, Carolin, et al.
Publicado: (2019)

Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
por: Turner, Hugo C, et al.
Publicado: (2018)

Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
por: Collyer, Benjamin S., et al.
Publicado: (2019)

Individual longitudinal compliance to neglected tropical disease mass drug administration programmes, a systematic review
por: Maddren, Rosie, et al.
Publicado: (2023)

The observed relationship between the degree of parasite aggregation and the prevalence of infection within human host populations for soil-transmitted helminth and schistosome infections
por: Kura, Klodeta, et al.
Publicado: (2022)

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
por: Toor, Jaspreet, et al.
Publicado: (2018)

The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
por: Anderson, Roy, et al.
Publicado: (2014)

The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
por: Werkman, Marleen, et al.
Publicado: (2017)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019)

Modeling the Interruption of the Transmission of Soil-Transmitted Helminths by Repeated Mass Chemotherapy of School-Age Children
por: Truscott, James, et al.
Publicado: (2014)

Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone
por: Sesay, Santigie, et al.
Publicado: (2014)

Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
por: Stylianou, Andria, et al.
Publicado: (2017)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
por: Ayabina, Diepreye Victoria, et al.
Publicado: (2021)

How important is the spatial movement of people in attempts to eliminate the transmission of human helminth infections by mass drug administration?
por: Collyer, Benjamin S., et al.
Publicado: (2023)

SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
por: Graham, Matthew, et al.
Publicado: (2021)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

The transmission dynamics of Strongyloides stercoralis and the impact of mass drug administration
por: Collyer, Benjamin S., et al.
Publicado: (2024)

Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
por: Geyer, Kathrin K., et al.
Publicado: (2011)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
por: Prada, Joaquín M., et al.
Publicado: (2018)

The cercarial glycocalyx of Schistosoma mansoni
Publicado: (1985)

CARBOHYDRATE METABOLISM OF SCHISTOSOMA MANSONI
por: Bueding, Ernest
Publicado: (1950)

Imatinib activity on Schistosoma mansoni
por: Katz, Naftale, et al.
Publicado: (2013)

Chlorination of Schistosoma mansoni cercariae
por: Braun, Laura, et al.
Publicado: (2020)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)

Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration
por: Berger, Duncan J., et al.
Publicado: (2021)

Identification of Schistosoma mansoni microRNAs
por: Simões, Mariana C, et al.
Publicado: (2011)

The genome of the blood fluke Schistosoma mansoni
por: Berriman, Matthew, et al.
Publicado: (2009)

Characterization of the Phytochelatin Synthase of Schistosoma mansoni
por: Ray, Debalina, et al.
Publicado: (2011)

Acute paraplegia caused by Schistosoma mansoni
por: Al-Mendalawi, Mahmood D.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ilvg5hatlc4n71ukjc5i3bk8pt